Skip to main content
. 2023 Nov 8;23:544. doi: 10.1186/s12872-023-03591-3

Table 3.

Summary of AEs

Dapagliflozin
(N = 30)
Placebo
(N = 30)
Hypoglycemia 1 (3.3) 0
Events consistent with urinary tract infection
 Male 0 0
 Female 2 (6.7) 0
Events consistent with genital infection
 Male 0 0
 Female 1 (3.3) 0
Events consistent with volume depletion 1 (3.3) 1 (3.3)